请后下载此文档！
听力学及言语疾病杂志JOURNAL OF AUDIOLOGY AND SPEECH PATHOLOGY
2003 Vol.11 No.3 P.221-223
肿瘤坏死因子α及其受体与分泌性中耳炎的关系
郭志强
黄孝文
崔永华
文章编号：1006-7299(2003)03-0221-03
分泌性中耳炎(secretory otitis media,SOM)是中耳的常见病、多发病,尤其在儿童中发病率很高.它以渗液滞留在中耳腔内而没有急性感染表现为特征.……
作者单位：郭志强（华中科技大学同济医学院附属同济医院耳鼻咽喉科,武汉,430030）
黄孝文（华中科技大学同济医学院附属同济医院耳鼻咽喉科,武汉,430030）
崔永华（华中科技大学同济医学院附属同济医院耳鼻咽喉科,武汉,430030）
参考文献：
［1］Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour- necrosis factor- alpha from cells[J]. Nature,1997, 385:729.
［2］Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour - necrosis factor - alpha [ J ].Nature, 1997,385: 733.
［3］姜云飞,白岚.膜肿瘤坏死因子的存在及其意义[J].国外医学免疫学分册,1995,3:151.
［4］李莉,李卓娅,李清芬,等.跨膜型与分泌型TNF对中性粒细胞功能的影响[J].中华微生物学和免疫学杂志,2001,21:453.
［5］Engelmann H, Novick D, Wallach D. Two tumor necrosis factorbinding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors[J]. J Biol Chem, 1990,265:1531.
［6］HiguchiM, Aggarwal BB. Differential roles of two types of the TNF receptor in TNF- induced cytotoxicity, DNA fragmentation, and differentiation[ J] .J Immunol, 1994, 152:4 017.
［7］Schutze S, Wiegmann K, Machleidt T, et al. TNF- induced activation of NF - kappa B[J]. Immunobiology, 1995,193:193.
［8］Brown DT, Litt M, Potsic WP. A study of mucous glycoproteins in secretory otitis media[ J]. Arch otolaryngol , 1985,111: 688.
［9］Carrie S, Hutton DA, Birchall JP, et al. Otitis media with effusion: components which contribute to the viscous properties[ J]. Acta otolaryngol,1992, 112:504.
［10］Lin J,Km Y,Juhn Sk, et al . Increase of mucous glycoprotein secretion by tumor necresis factor - α via a protein kinase C - dependent mechanism in cultured chinchilla middle ear epithelial cells[J]. Ann Otol Rhinol Laryngol. 1998,107:213.
［11］Lin J, Haruta A, Kawano H, et al. Iuduction of mucin gene expression in middle ear of rats by tumor necrosis factor - α: potential cause for mucoid otitis media[ J]. J Infect Dis, 2000, 182: 882.
［12］Ophir D, Hahn T, Schattner A, et al. tumor necrosis factor in media ear effusion[J]. Arch otolaryngol Head Neck Surg, 1988,114:1 256.
［13］Catanzaro A, Ryan A, Batcher S, et al. The response to human rIL -1, rIL- 2, and rTNF in the middle ear of guinea pigs[J]. Laryngoscope, 1991, 101:271.
［14］Yellon RF, Leonard G, Marucha PT, et al. Characterization of cytokines present in middle ear effusions[J]. Laryngoscope, 1991, 101:165.
［15］Yellon RF, Doyle WJ, Whiteside TL, et al. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions[ J]. Arch Otolaryngol Head Neck Surg, 1995, 121:865.
［16］Willett DN, Rezaee RP, Billy JM, et al. Relationship of endotoxin to tumor necrosis factor - alpha and interleukin - 1 beta in children with otitis media with effusion[J]. Ann Otol Rhinol Laryngol, 1998, 107:28.
［17］Schousboe LP, Ovesen T, Eckhardt L, et al. How does endotoxin trigger inflammation in otitis media with effusion [ J ] ? Laryngoscope, 2001,111:297.
［18］Maxwell K, Leonard G, Kreutzer DL. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor[ J ]. Arch Otolaryngol Head Neck Surg, 1997,123:984.
［19］Lee DH, ParkYS, JungTT, etal. Effect of tumor necrosis factor- alpha on experimental otitis media with effusion [ J ]. Laryngoscope,2001,111:728.
［20］Jeon EJ, Park YS, Choi YC, et al. Effectof inhibitor of turmor necrosis factor- alpha on experimental otitis media with effusion[J]. Ann Otol Rhinol Laryngol,2001,110:917.
［21］Staudinger T, Presterl E, Graninger W, et al. Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock[J]. Intensive Care Med, 1996,22:888.
［22］Givner LB, Gray L, O'Shea TM. Antibodies to tumor necrosis factor-alpha: use as adjunctive therapy in established group B streptococcal disease in newborn rats[J]. Pediatr Res, 1995,38:551.
［23］Van Zee KJ, Moldawer LL, Oldenburg HS,et al. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55 - kDa TNF receptor (CD120a) - Ig fusion protein, Ro 45 - 2081 [J] .J Immunol, 1996,156:2 221.